XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 42 filers reported holding XENON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $127,000 | -14.2% | 8,293 | 0.0% | 0.05% | +12.8% |
Q2 2021 | $148,000 | 0.0% | 8,293 | 0.0% | 0.05% | +20.5% |
Q1 2021 | $148,000 | +15.6% | 8,293 | 0.0% | 0.04% | +143.8% |
Q4 2020 | $128,000 | +39.1% | 8,293 | 0.0% | 0.02% | -40.7% |
Q3 2020 | $92,000 | -11.5% | 8,293 | 0.0% | 0.03% | -68.6% |
Q2 2020 | $104,000 | +10.6% | 8,293 | 0.0% | 0.09% | -13.1% |
Q1 2020 | $94,000 | -13.8% | 8,293 | 0.0% | 0.10% | +110.6% |
Q4 2019 | $109,000 | +45.3% | 8,293 | 0.0% | 0.05% | +62.1% |
Q3 2019 | $75,000 | -8.5% | 8,293 | 0.0% | 0.03% | +11.5% |
Q2 2019 | $82,000 | -2.4% | 8,293 | 0.0% | 0.03% | -66.2% |
Q1 2019 | $84,000 | +61.5% | 8,293 | 0.0% | 0.08% | +5.5% |
Q4 2018 | $52,000 | -52.3% | 8,293 | 0.0% | 0.07% | +37.7% |
Q3 2018 | $109,000 | +43.4% | 8,293 | 0.0% | 0.05% | +65.6% |
Q2 2018 | $76,000 | +230.4% | 8,293 | 0.0% | 0.03% | +220.0% |
Q1 2018 | $23,000 | 0.0% | 8,293 | 0.0% | 0.01% | +25.0% |
Q4 2017 | $23,000 | -4.2% | 8,293 | 0.0% | 0.01% | +33.3% |
Q3 2017 | $24,000 | -7.7% | 8,293 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $26,000 | -21.2% | 8,293 | 0.0% | 0.01% | -14.3% |
Q1 2017 | $33,000 | -98.7% | 8,293 | -97.4% | 0.01% | -98.8% |
Q4 2016 | $2,465,000 | – | 320,061 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |